Colitis Ulcerative clinical trials

Explore recruiting colitis ulcerative clinical trials.

Recruiting colitis ulcerative studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colitis Ulcerative trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1 study on SAR443122 bioavailability and food effect in healthy adults

Netherlands

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants with Moderately to Severely Active Ulcerative Colitis

Italy, Greece, Netherlands, Poland, Germany, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo controlled, dose ­finding study to assess the efficacy and safety of SAR443122 in adult patients with moderate to severe ulcerative colitis

Czechia, France, Spain, Germany, Hungary, Netherlands +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled, single and multiple-dose-escalation, phase 1 study in healthy volunteers and patients with ulcerative colitis to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GRT-001 (MONOlith trial)

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate-to-severe ulcerative colitis

Croatia, Romania, Greece, Italy, Belgium, Germany +6 more

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label randomized trial COmparing staNdard of care versus Treat to target with telemonitoRing and patient education in patients with ulcerative cOlitis initiating adalimumab : The CONTROL trial

France

Therapeutic use (Phase IV) EU CTIS Study details

Colitis Ulcerative trials by city

Colitis Ulcerative in Toronto Colitis Ulcerative in Vancouver Colitis Ulcerative in Montreal Colitis Ulcerative in Calgary Colitis Ulcerative in Edmonton Colitis Ulcerative in Ottawa Colitis Ulcerative in Winnipeg Colitis Ulcerative in Quebec City Colitis Ulcerative in Hamilton Colitis Ulcerative in Kitchener Colitis Ulcerative in London Colitis Ulcerative in Halifax Colitis Ulcerative in New York Colitis Ulcerative in Los Angeles Colitis Ulcerative in Chicago Colitis Ulcerative in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease